Pharmaceutical

Biochemistry Pioneer and DNA Ligase Co-Discoverer Dies at 101
Clinical & Pharma Biochemistry Pioneer and DNA Ligase Co-Discoverer Dies at 101

The sophisticated methods used today to engineer life-saving medications and map complex genomes trace their lineage back to the purification of DNA-altering enzymes in Lehman’s mid-century laboratories. This recent passing of I. Robert Lehman, PhD, at the age of 101 at his home on the Stanford

How Is AI Transforming the Future of Drug Discovery?
Tech & Innovation How Is AI Transforming the Future of Drug Discovery?

The pursuit of life-saving medicine has historically been a gamble of astronomical proportions, often requiring billions of dollars and over a decade of labor for a single successful outcome. As of 2026, the pharmaceutical landscape is undergoing a radical transition from this artisanal,

How Do Interferons Drive Chronic Tumor Growth?
Clinical & Pharma How Do Interferons Drive Chronic Tumor Growth?

Protective cellular mechanisms are sometimes subverted by chronic stress, leading to a state where the immune system's own signaling proteins protect the survival of malignancy. This physiological irony is at the heart of recent research conducted by the Salk Institute, which was published on

Can mRNA Cancer Vaccines Overcome Production Hurdles?
Management & Administration Can mRNA Cancer Vaccines Overcome Production Hurdles?

Unlike traditional vaccines designed for broad populations, personalized neoantigen therapies must be engineered to match the unique genetic signatures found only on an individual's tumor cells. This biological precision represents the pinnacle of modern oncology, moving away from the

How Has Specialists in Dermatology Evolved Over 20 Years?
Clinical & Pharma How Has Specialists in Dermatology Evolved Over 20 Years?

The transition from a two-person surgical team to a multi-provider practice underscores the growing need for specialized skin care in the rapidly expanding northern Houston suburbs. Since its founding in 2006, Specialists in Dermatology has navigated a path of steady growth, rooted in the initial

Pharma Patent Reform: Ending Monopolies to Lower Drug Costs
Management & Administration Pharma Patent Reform: Ending Monopolies to Lower Drug Costs

Generic drugs and biosimilars currently save American consumers roughly 467 billion dollars annually by providing affordable alternatives to brand-name medications. This staggering figure underscores the essential role that market competition plays in maintaining the financial health of the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later